{"chunk_type":"transcript_chunk","text":"### 1) Low Risk (Stable)\n- **ì •ì˜:** í˜ˆì•• ì •ìƒ, RV ê¸°ëŠ¥ ì •ìƒ.\n- **ì¹˜ë£Œ:** **Anticoagulation** (Heparin, LMWH, DOACs). ëª¸ì´ ì•Œì•„ì„œ í˜ˆì „ ë…¹ì¼ ë•Œê¹Œì§€ ë” ì•ˆ ìƒê¸°ê²Œ ë§‰ì•„ì¤Œ.\n### 2) Submassive PE (The Gray Area)\n- **ì •ì˜:** **í˜ˆì••ì€ ì •ìƒ(Stable)**ì´ì§€ë§Œ, **RV Dysfunction** ì¦ê±°ê°€ ìˆìŒ.\n    - Echoì—ì„œ RV Dilation.\n    - Troponin ìƒìŠ¹, BNP ìƒìŠ¹.\n- **ì¹˜ë£Œ:** ì¼ë‹¨ì€ **Anticoagulation**.\n    - ICUì—ì„œ ë§¤ì˜ ëˆˆìœ¼ë¡œ ê°ì‹œ(Hawk-like watch). í˜ˆì•• ë–¨ì–´ì§€ë©´ ë°”ë¡œ Massiveë¡œ ê°„ì£¼í•˜ê³  tPA ê³ ë ¤.\n### 3) Massive PE (Unstable = Emergency)\n- **ì •ì˜:** **Hypotension (SBP < 90)** ë˜ëŠ” Shock.\n- **ì¹˜ë£Œ:** **Thrombolysis (tPA)**.\n    - ì•½ë¬¼ë¡œ ì „ì‹  í˜ˆì „ì„ ë…¹ì„(Systemic Fibrinolysis).\n    - **tPA ê¸ˆê¸°ì‹œ:** Surgical Embolectomy (ìˆ˜ìˆ ) ë˜ëŠ” Catheter-directed thrombolysis.\n### 4) IVC Filter\n- **ì ì‘ì¦:**\n    1. í•­ì‘ê³ ì œ **ì ˆëŒ€ ê¸ˆê¸°** (Active GI Bleed, Brain Bleed).\n    2. í•­ì‘ê³ ì œë¥¼ ì¼ëŠ”ë°ë„ **PEê°€ ì¬ë°œ**í•¨ (Failure of anticoagulation).\n- *Note:* ì¥ê¸°ì ìœ¼ë¡œëŠ” í•„í„° ìì²´ê°€ í˜ˆì „ ì†ŒìŠ¤(Source)ê°€ ë˜ì–´ DVT ìœ„í—˜ì„ ë†’ì¼ ìˆ˜ ìˆìŒ.\n---\n## 7. Special High-Yield Variants (íŠ¹ìˆ˜ ìƒí™©)\n### ğŸ¦´ Fat Embolism Syndrome\n- **ì›ì¸:** ì¥ê³¨ ê³¨ì ˆ(Long bone fx, Femur) í›„ ê³¨ìˆ˜ ì§€ë°© ìœ ì¶œ.\n- **íƒ€ì´ë°:** ë¶€ìƒ í›„ **24~72ì‹œê°„** ë’¤ ë°œë³‘.\n- **Classic Triad:**\n    1. **Hypoxemia:** í˜¸í¡ ê³¤ë€.\n    2. **Neurologic abnormalities:** í˜¼ë€(Confusion), ì˜ì‹ ë³€í™”.\n    3. **Petechial Rash (â˜…):** ê°€ìŠ´, ê²¨ë“œë‘ì´(Axilla), ëª©ì— ë¶‰ì€ ë°˜ì . (ê°€ì¥ íŠ¹ì§•ì ).\n- **ì¹˜ë£Œ:** **Supportive Care** (ì‚°ì†Œ ê³µê¸‰). í—¤íŒŒë¦° ì•ˆ ì”€(ì§€ë°©ì´ë¼ ì•ˆ ë…¹ìŒ). ì˜ˆë°©(ì¡°ê¸° ê³¨ì ˆ ê³ ì •)ì´ ìµœì„ .\n### ğŸ«§ Air Embolism\n- **ì›ì¸:** ì¤‘ì‹¬ì •ë§¥ê´€(Central line) ì œê±° ì‹œ, ìˆ˜ìˆ  ì¤‘, ìŠ¤ì¿ ë²„ ë‹¤ì´ë¹™.\n- **ê¸°ì „:** ê³µê¸° ë°©ìš¸ì´ ìš°ì‹¬ì‹¤(RV) ìœ ì¶œë¡œ(Outflow tract)ë¥¼ ë§‰ì•„ë²„ë¦¼ (Air Lock).\n- **ì¹˜ë£Œ:** **Durant's Maneuver (Left Lateral Decubitus)**.\n    - í™˜ìë¥¼ **ì™¼ìª½ìœ¼ë¡œ ëˆ•íˆê³  ë¨¸ë¦¬ë¥¼ ë‚®ì¶¤**. â˜…\n    - *ì›ë¦¬:* ê³µê¸°ë¥¼ ê°€ë²¼ìš°ë‹ˆê¹Œ ìš°ì‹¬ì‹¤ ê¼­ëŒ€ê¸°(Apex)ë¡œ ë„ì›Œ ë³´ë‚´ê³ , í˜ˆì•¡ì€ ì•„ë˜ìª½ìœ¼ë¡œ í˜ëŸ¬ë‚˜ê°€ê²Œ í•¨.\n### ğŸ¤° Amniotic Fluid Embolism\n- **ìƒí™©:** ë¶„ë§Œ ì¤‘/ì§í›„.\n- **ì¦ìƒ:** ê°‘ì‘ìŠ¤ëŸ¬ìš´ ì‡¼í¬ + **DIC**(í”¼ê°€ ì•ˆ ë©ˆì¶¤).\n- **ì˜ˆí›„:** ì‚¬ë§ë¥  ë§¤ìš° ë†’ìŒ.\n### ğŸ¦€ Trousseau's Syndrome\n- **ì¦ìƒ:** ì—¬ê¸°ì €ê¸° ì˜®ê²¨ ë‹¤ë‹ˆëŠ” ì •ë§¥ì—¼ (Migratory Thrombophlebitis).\n- **ì˜ë¯¸:** **Occult Malignancy** (ìˆ¨ê²¨ì§„ ì•”, íŠ¹íˆ ì·Œì¥ì•”) ì˜ì‹¬í•´ì•¼ í•¨.\n## 8. Deep Vein Thrombosis (DVT): The Source\n**\"ëª¨ë“  PEëŠ” ì–´ë””ì„ ê°€ ë‚ ì•„ì™”ë‹¤. ê·¸ê³³ì„ ì°¾ì•„ë¼.\"**","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-41","focus_area":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","tags":["usmle-step2","core","treatment","tree"]}
{"chunk_type":"transcript_chunk","text":"PEë¥¼ ì§„ë‹¨í•˜ê³  ëì´ ì•„ë‹™ë‹ˆë‹¤. í˜ˆì „ì´ ì–´ë””ì„œ ì™”ëŠ”ì§€(Source)ë¥¼ ì•„ëŠ” ê²ƒì´ ì˜ˆí›„ì™€ ì¹˜ë£Œì— ì§ê²°ë©ë‹ˆë‹¤.\n### A. Location Matters: Proximal vs. Distal (ì¡±ë³´ ë­í‚¹ 1ìœ„)\nëª¨ë“  DVTê°€ íë¡œ ë‚ ì•„ê°€ëŠ” ê²ƒì€ ì•„ë‹™ë‹ˆë‹¤. ìœ„ì¹˜ê°€ í•µì‹¬ì…ë‹ˆë‹¤.\n1. **Proximal DVT (ìœ„í—˜êµ° â˜…):**\n    - **ìœ„ì¹˜:** **Popliteal(ì˜¤ê¸ˆì •ë§¥)**, **Femoral(ëŒ€í‡´ì •ë§¥)**, **Iliac(ì¥ê³¨ì •ë§¥)** veins.\n    - **íŠ¹ì§•:** ì—¬ê¸°ì„œ ìƒê¸´ í˜ˆì „ì´ ë©ì–´ë¦¬ê°€ í¬ê³ , íë¡œ ë‚ ì•„ê°ˆ í™•ë¥ (Embolization risk)ì´ ë§¤ìš° ë†’ìŠµë‹ˆë‹¤. PEì˜ 90% ì´ìƒì´ ì—¬ê¸°ì„œ ì˜µë‹ˆë‹¤.\n    - **ì¹˜ë£Œ:** ë¬´ì¡°ê±´ **Anticoagulation**.\n2. **Distal DVT (Calf Veins):**\n    - **ìœ„ì¹˜:** ë¬´ë¦ ì•„ë˜ ì¢…ì•„ë¦¬ ì •ë§¥ë“¤.\n    - **íŠ¹ì§•:** ì‘ì•„ì„œ íë¡œ ë‚ ì•„ê°€ë„ ì‹¬ê°í•œ PEë¥¼ ì˜ ì•ˆ ì¼ìœ¼í‚µë‹ˆë‹¤.\n    - **ê´€ë¦¬:** ë¬´ì¡°ê±´ ì•½ì„ ì“°ê¸°ë³´ë‹¤, ì´ˆìŒíŒŒ(Serial Ultrasound)ë¡œ ìœ„ë¡œ ì˜¬ë¼ì˜¤ëŠ”ì§€(Propagation) ì§€ì¼œë³´ê¸°ë„ í•©ë‹ˆë‹¤.\n### B. Upper Extremity DVT: Paget-Schroetter Syndrome\n\"ë‹¤ë¦¬ì—ë§Œ ìƒê¸°ëŠ” ê²Œ ì•„ë‹ˆë‹¤.\" (ì˜¤ë””ì˜¤ì—ì„œ ì–¸ê¸‰ëœ 'Effort Thrombosis')\n- **íƒ€ê²Ÿ:** ì Šê³  ê±´ê°•í•œ ìš´ë™ì„ ìˆ˜ (ì•¼êµ¬ íˆ¬ìˆ˜, ì—­ë„ ì„ ìˆ˜, ìˆ˜ì˜ ì„ ìˆ˜ ë“±).\n- **ê¸°ì „:** ì–´ê¹¨ ê·¼ìœ¡(Scalene muscles ë“±)ì´ ë„ˆë¬´ ë¹„ëŒ€í•´ì ¸ì„œ ì‡„ê³¨ ë°‘ì˜ ì •ë§¥(Subclavian vein)ì„ **ë¬¼ë¦¬ì ìœ¼ë¡œ ëˆŒëŸ¬ì„œ(Compress)** í˜ˆì „ì´ ìƒê¹€.\n- **ì¦ìƒ:** ì Šì€ ë‚¨ìê°€ ìš´ë™ í›„ ê°‘ìê¸° íŒ”ì´ ë¶“ê³  ì•„í””.\n- **ì¹˜ë£Œ:** ì¼ë°˜ DVTì™€ ë‹¤ë¥´ê²Œ **Catheter-directed Thrombolysis**ë¥¼ ë” ì ê·¹ì ìœ¼ë¡œ ê³ ë ¤í•˜ê³ , ê·¼ë³¸ ì›ì¸ í•´ê²°ì„ ìœ„í•´ **ìˆ˜ìˆ (ë¼ˆë‚˜ ê·¼ìœ¡ ì œê±°)**ì´ í•„ìš”í•  ìˆ˜ ìˆìŒ.\n### C. unprovoked DVT in an elderly â†’ ì•” ì˜ì‹¬ â†’ì•” ê²€ì‚¬ â˜…\n### D. Phlegmasia Cerulea Dolens (The Limb Threat)\nPEì—ì„œì˜ 'Massive PE'ì— í•´ë‹¹í•˜ëŠ”, ë‹¤ë¦¬ì—ì„œì˜ ì‘ê¸‰ ìƒí™©ì…ë‹ˆë‹¤.\n- **ì˜ë¯¸:** **\"Painful Blue Edema\"** (ì•„í”„ê³  íŒŒë—ê²Œ ë¶“ëŠ”ë‹¤).\n- **ê¸°ì „:** ë‹¤ë¦¬ì˜ **ëª¨ë“ ** ì •ë§¥ì´ í˜ˆì „ìœ¼ë¡œ ê½‰ ë§‰í˜ â†’ í”¼ê°€ ì „í˜€ ëª» ë¹ ì ¸ë‚˜ê° â†’ ë™ë§¥í˜ˆë„ ëª» ë“¤ì–´ì˜´(ì••ë ¥ ì°¨ì´ ë•Œë¬¸ì—) â†’ **ë‹¤ë¦¬ ê´´ì‚¬(Ischemia/Gangrene)**.\n- **ì¦ìƒ:** ë‹¤ë¦¬ê°€ ì—„ì²­ë‚˜ê²Œ ë¶“ê³ , ì‹œí¼ë ‡ê²Œ ë³€í•˜ë©°(Cyanosis), ë§¥ë°•ì´ ì•ˆ ë§Œì ¸ì§ˆ ìˆ˜ë„ ìˆìŒ.\n- **ì¹˜ë£Œ:** ë‹¨ìˆœ í•­ì‘ê³ ì œë¡œëŠ” ë¶€ì¡±í•¨. ë‹¤ë¦¬ë¥¼ ì ˆë‹¨(Amputation)í•˜ì§€ ì•Šìœ¼ë ¤ë©´ **Thrombolysis(í˜ˆì „ìš©í•´ìˆ )** ë˜ëŠ” **Thrombectomy(ìˆ˜ìˆ ì  ì œê±°)**ê°€ ì¦‰ì‹œ í•„ìš”í•¨.\n### E. Diagnosis: Ultrasound Strategy\n- **ê²€ì‚¬ëª…:** **Compression Ultrasonography**.\n- **ì›ë¦¬:** ì •ìƒ ì •ë§¥ì€ ì´ˆìŒíŒŒ í”„ë¡œë¸Œë¡œ ëˆ„ë¥´ë©´ ì°Œê·¸ëŸ¬ì ¸ì•¼(Collapsible) í•¨. ì•ˆ ì°Œê·¸ëŸ¬ì§€ë©´(Non-compressible) ì•ˆì— ë­”ê°€ ê½‰ ì°¨ ìˆë‹¤ëŠ” ëœ» = **DVT ì–‘ì„±**.\n---","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-61","focus_area":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","tags":["usmle-step2","core","diagnosis"]}
{"chunk_type":"recap_summary","text":"## 9. Final Decision Table (Recap Summary)\n| **ìƒí™© (Patient Snapshot)** | **í–‰ë™ (The Move)** |\n| --- | --- |\n| **Stable Patient (BP > 90)** | Wells Score ê³„ì‚° |\n| **Wells â‰¤ 4 (Unlikely)** | D-dimer |\n| **Wells > 4 (Likely)** | CT Angio (CTPA) |\n| **Likely PE + Severe Distress** | **Heparin ë¨¼ì €** íˆ¬ì—¬ í›„ CT ì´ë™ |\n| **Unstable (BP < 90, Massive)** | Bedside Echo â†’ **tPA (Thrombolysis)** |\n| **Renal Failure / Pregnancy** | V/Q Scan |\n| **Femur Fx + Rash + Confusion** | Fat Embolism (Supportive Care) |\n| **Central Line removal + Shock** | Left Lateral Decubitus (Air Embolism) |\n| **75, unprovoked DVT** | cancer screening |\n# ğŸ« USMLE Deep Dive: ARDS (Acute Respiratory Distress Syndrome)\n**Topic:** Berlin Criteria, Ventilation Strategy (LTVV), PEEP, Prone Positioning\n## ğŸŒ³ The Big Picture: Hypoxemia Algorithm\ní™˜ìê°€ ìˆ¨ì´ ì°¨ì„œ X-rayë¥¼ ì°ì—ˆëŠ”ë° **ì–‘ìª½ íê°€ í•˜ì–—ê²Œ(Bilateral White-out)** ë³€í–ˆìŠµë‹ˆë‹¤. ì´ê²Œ ì‹¬ì¥ ë•Œë¬¸ì¼ê¹Œìš”, í ë•Œë¬¸ì¼ê¹Œìš”?\nPlaintext\n`Bilateral Opacities on CXR (White-out)\nâ”‚\nâ”œâ”€â”€ Cardiogenic Pulmonary Edema (ì‹¬ë¶€ì „)\nâ”‚   â”œâ”€â”€ PCWP > 18 mmHg (High)\nâ”‚   â”œâ”€â”€ JVD present, S3 gallop\nâ”‚   â””â”€â”€ Rx: Diuretics (Lasix), Inotropes\nâ”‚\nâ””â”€â”€ Non-Cardiogenic Pulmonary Edema (ARDS)\n    â”œâ”€â”€ PCWP < 18 mmHg (Normal/Low)\n    â”œâ”€â”€ Berlin Criteria ë§Œì¡± (1ì£¼ì¼ ì´ë‚´ ë°œë³‘)\n    â”œâ”€â”€ P/F Ratio < 300\n    â””â”€â”€ Rx: Mechanical Ventilation (Low Tidal Volume, High PEEP)`\n---\n## 1. Pathophysiology: \"The Leaky Capillary\"","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-75","focus_area":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","tags":["usmle-step2","core","recap","diagnosis","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"ARDSëŠ” íê°€ ë¬¼ì— ë¹ ì§„ ê²Œ ì•„ë‹ˆë¼, í˜ˆê´€ì—ì„œ ë¬¼ì´ ìƒˆì–´ ë‚˜ì™€ íí¬ë¥¼ ë§ê°€ëœ¨ë¦¬ëŠ” ë³‘ì…ë‹ˆë‹¤.\n- **Mechanism:** Sepsisë‚˜ Trauma ê°™ì€ ì „ì‹  ì—¼ì¦ ë°˜ì‘ â†’ ì‚¬ì´í† ì¹´ì¸ í­í’(Cytokine Storm) â†’ íí˜ˆê´€ íˆ¬ê³¼ì„± ì¦ê°€ â†’ ë‹¨ë°±ì§ˆì´ í’ë¶€í•œ ì‚¼ì¶œì•¡ì´ íí¬ë¡œ ìƒ™ë‹ˆë‹¤.\n- **Result:**\n    - **Hyaline Membrane:** ì£½ì€ ì„¸í¬ ì°Œêº¼ê¸°ë“¤ì´ ë§‰ì„ í˜•ì„±í•´ ê°€ìŠ¤ êµí™˜ì„ ì°¨ë‹¨í•©ë‹ˆë‹¤.\n    - **Baby Lungs:** ì •ìƒì ìœ¼ë¡œ ê¸°ëŠ¥í•˜ëŠ” íí¬ê°€ ê·¹ì†Œìˆ˜ë¡œ ì¤„ì–´ë“¤ì–´, ë§ˆì¹˜ ì•„ê¸° íì²˜ëŸ¼ ìš©ì ì´ ì‘ì•„ì§‘ë‹ˆë‹¤.\n    - **Shunt Physiology:** í”¼ê°€ íë¥¼ ì§€ë‚˜ê°€ë„ ì‚°ì†Œë¥¼ ëª» ë°›ìŠµë‹ˆë‹¤ (V/Q = 0). ì‚°ì†Œë¥¼ ì•„ë¬´ë¦¬ ì¤˜ë„(100% O2) êµì •ì´ ì˜ ì•ˆ ë©ë‹ˆë‹¤.\n---\n## 2. Diagnosis: Berlin Criteria\nARDS ì§„ë‹¨ì„ ìœ„í•œ 4ê°€ì§€ í•„ìˆ˜ ì¡°ê±´ì…ë‹ˆë‹¤. ì‹œí—˜ì—ì„œ \"ARDSì¸ê°€?\"ë¥¼ ë¬¼ìœ¼ë©´ ì´ ê¸°ì¤€ì„ ëŒ€ì…í•˜ì„¸ìš”.\n1. **Timing (ì‹œê¸°):** ì›ì¸ ì§ˆí™˜(Sepsis, Pneumonia ë“±) ë°œìƒ **1ì£¼ì¼ ì´ë‚´(Within 1 week)** ê¸‰ì„± ë°œë³‘.\n2. **Imaging (ì˜ìƒ):** X-rayë‚˜ CTìƒ **Bilateral Opacities** (ì–‘ìª½ í ì¹¨ìœ¤).\n3. **Origin (ì›ì¸):** **Not fully explained by heart failure**. (ì‹¬ì¥ ì´ˆìŒíŒŒ ì •ìƒ, í˜¹ì€ PCWP < 18mmHg).\n4. **Oxygenation (ì‚°ì†Œí™”):** P/F Ratio (PaO2 / FiO2)ë¡œ ì¤‘ì¦ë„ ë¶„ë¥˜.\n    - **Mild:** 200 < P/F â‰¤ 300\n    - **Moderate:** 100 < P/F â‰¤ 200\n    - **Severe:** P/F â‰¤ 100\n---\n## 3. Treatment: Lung Protective Ventilation â˜…\nê°€ì¥ ì¤‘ìš”í•œ íŒŒíŠ¸ì…ë‹ˆë‹¤. ARDS í™˜ìëŠ” ì‚°ì†Œ ë¶€ì¡±ìœ¼ë¡œ ì£½ëŠ” ê²Œ ì•„ë‹ˆë¼, **ì¸ê³µí˜¸í¡ê¸°ê°€ íë¥¼ ì°¢ì–´ì„œ(Volutrauma)** ì£½ìŠµë‹ˆë‹¤.\n### A. Low Tidal Volume Ventilation (LTVV)â˜…â˜…â˜…â˜…\n**Goal:** íí¬ ê³¼íŒ½ì°½ ë°©ì§€ (Prevent Volutrauma/Barotrauma).\n- **Setting:** **6 mL/kg** of Predicted Body Weight (PBW). (ì¼ë°˜ì ì¸ 8-10mL/kgë³´ë‹¤ í›¨ì”¬ ì ê²Œ ì¤ë‹ˆë‹¤).\n    - *ì£¼ì˜:* ì‹¤ì œ ì²´ì¤‘ì´ ì•„ë‹ˆë¼ **í‚¤(Height)**ë¡œ ê³„ì‚°í•œ ì˜ˆìƒ ì²´ì¤‘ì„ ì”ë‹ˆë‹¤. ì‚´ìª˜ë‹¤ê³  íê°€ ì»¤ì§€ëŠ” ê±´ ì•„ë‹ˆë‹ˆê¹Œìš”.\n- **Mortality Benefit:** ì‚¬ë§ë¥ ì„ ë‚®ì¶”ëŠ” ê²ƒì´ ì…ì¦ëœ **ê°€ì¥ ì¤‘ìš”í•œ ì¹˜ë£Œ**ì…ë‹ˆë‹¤.\n### B. PEEP (Positive End-Expiratory Pressure)\n- **Role:** ìˆ¨ì„ ë‚´ì‰´ ë•Œ íí¬ê°€ ìª¼ê·¸ë¼ë“¤ì§€ ì•Šê²Œ ì••ë ¥ì„ ê±¸ì–´ì¤ë‹ˆë‹¤ (Recruitment). ì°Œê·¸ëŸ¬ì§„ íí¬ë¥¼ í´ì„œ ì‚°ì†Œ êµí™˜ ë©´ì ì„ ëŠ˜ë¦½ë‹ˆë‹¤.\n- **Strategy:** ì‚°ì†Œ ë†ë„(FiO2)ë¥¼ ë¬´ì‘ì • ë†’ì´ëŠ” ê²ƒë³´ë‹¤, **PEEPì„ ë†’ì—¬ì„œ** FiO2ë¥¼ 60% ì´í•˜ë¡œ ë‚®ì¶”ëŠ” ê²ƒì´ ëª©í‘œì…ë‹ˆë‹¤ (ì‚°ì†Œ ë…ì„± ì˜ˆë°©).\n### C. Permissive Hypercapnia (í—ˆìš©ì  ê³ íƒ„ì‚°í˜ˆì¦) 7.25ê¹Œì§€ëŠ” ê´€ì°°\n- TV(Tidal Volume)ë¥¼ 6mL/kgë¡œ ì¤„ì´ë©´ í™˜ê¸°ê°€ ë¶€ì¡±í•´ì„œ **CO2ê°€ ìŒ“ì…ë‹ˆë‹¤(Acidosis)**.\n- **Rule:** pHê°€ **7.25** ì´ìƒì´ê¸°ë§Œ í•˜ë©´, PCO2ê°€ ë†’ì•„ë„ **ê·¸ëƒ¥ ë‘¡ë‹ˆë‹¤**. CO2 ì¡ê² ë‹¤ê³  TVë¥¼ ëŠ˜ë¦¬ë©´ íê°€ í„°ì§€ê¸° ë•Œë¬¸ì…ë‹ˆë‹¤.\n---\n## 4. Refractory Hypoxemia Strategies\nì¸ê³µí˜¸í¡ê¸°ë¥¼ ë‹¬ì•˜ëŠ”ë°ë„ ì‚°ì†Œí¬í™”ë„ê°€ ì•ˆ ì˜¤ë¥´ë©´ ì–´ë–»ê²Œ í• ê¹Œìš”?\n### A. Prone Positioning (ë³µìœ„ ìš”ë²•) â˜…","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-85","focus_area":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"- **What:** í™˜ìë¥¼ **ì—ë“œë ¤ ëˆ•í™ë‹ˆë‹¤(Face down)**.\n- **Mechanism:** ì‹¬ì¥ì— ëˆŒë ¤ ìˆë˜ ë“± ìª½ í(Dorsal lung)ê°€ í´ì§€ë©´ì„œ í™˜ê¸°-ê´€ë¥˜ ë¶ˆê· í˜•(V/Q mismatch)ì´ ê°œì„ ë©ë‹ˆë‹¤.\n- **Indication:** **Severe ARDS (P/F Ratio < 150)** í™˜ìì—ì„œ í•˜ë£¨ 16ì‹œê°„ ì´ìƒ ì‹œí–‰ ì‹œ **ì‚¬ë§ë¥  ê°ì†Œ** íš¨ê³¼ê°€ ìˆìŠµë‹ˆë‹¤.\n### B. Paralytics (Neuromuscular Blockade)\n- í™˜ìê°€ ì¸ê³µí˜¸í¡ê¸°ì™€ ì‹¸ìš°ë©°(Fighting) í ì†ìƒì„ ì•…í™”ì‹œí‚¬ ë•Œ, **Cisatracurium** ê°™ì€ ê·¼ì´ì™„ì œë¥¼ ì¨ì„œ í˜¸í¡ ê·¼ìœ¡ì„ ë§ˆë¹„ì‹œí‚µë‹ˆë‹¤. ì´ˆê¸°(48ì‹œê°„ ì´ë‚´)ì— ì‚¬ìš©í•˜ë©´ ìƒì¡´ìœ¨ì„ ë†’ì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n### C. ECMO (ì²´ì™¸ë§‰ì‚°ì†Œê³µê¸‰)\n- ëª¨ë“  ë°©ë²•ì´ ì‹¤íŒ¨í–ˆì„ ë•Œ ìµœí›„ì˜ ìˆ˜ë‹¨(Last resort)ì…ë‹ˆë‹¤.\n---\n## 5. Common Causes & Look-alikes\n- **Sepsis:** ê°€ì¥ í”í•œ ì›ì¸.\n- **Pancreatitis:** ì·Œì¥ íš¨ì†Œê°€ ì „ì‹ ì„ ëŒë©° íë¥¼ ê³µê²©.\n- **TRALI (Transfusion Related Acute Lung Injury):** ìˆ˜í˜ˆ í›„ 6ì‹œê°„ ì´ë‚´ì— ê°‘ìê¸° ìˆ¨ì´ ì°¸. ARDSì˜ ì¼ì¢…ì…ë‹ˆë‹¤. no cardiomegaly, no diuretics.\n    - vs TACO (overload): ì´ë‡¨ì œ ì‚¬ìš©, cardiomegaly æœ‰\n- *Key Distinction:*\n    - **PCWP (Wedge Pressure):**\n        - ARDS: **Normal or Low (< 18)**.\n        - CHF (Cardiogenic): **High (> 18)**.\n    - ì´ ìˆ˜ì¹˜ë¥¼ ì£¼ë©´ ì§„ë‹¨ì´ ëë‚œ ê±°ë‚˜ ë‹¤ë¦„ì—†ìŠµë‹ˆë‹¤.\n---\n## ğŸ¯ Recap (High Yield Summary)\nARDS íŒŸìºìŠ¤íŠ¸ì˜ í•µì‹¬ ìš”ì•½ì…ë‹ˆë‹¤.\n1. **Diagnosis (Berlin):** 1ì£¼ì¼ ì´ë‚´ ê¸‰ì„± ë°œë³‘ + ì–‘ì¸¡ì„± íì¹¨ìœ¤ + **ì‹¬ë¶€ì „ ì•„ë‹˜ (PCWP < 18)**.\n2. **Ventilation Rule #1:** **Low Tidal Volume (6 mL/kg)**. ì´ê²ƒë§Œì´ **ì‚¬ë§ë¥ (Mortality)**ì„ ë‚®ì¶¥ë‹ˆë‹¤.\n3. **Permissive Hypercapnia:** TVë¥¼ ë‚®ì¶°ì„œ CO2ê°€ ì˜¤ë¥´ë”ë¼ë„, pH > 7.25ë©´ **í—ˆìš©(Permit)**í•´ë¼.\n4. **Oxygenation:** ì‚°ì†Œê°€ ë¶€ì¡±í•˜ë©´ FiO2ë¥¼ ì˜¬ë¦¬ê¸° ì „ì— **PEEP**ì„ ì˜¬ë ¤ì„œ íí¬ë¥¼ í´ë¼.\n5. **Refractory:** P/F < 150ì´ë©´ í™˜ìë¥¼ **ì—ë“œë ¤ ëˆ•í˜€ë¼(Prone Positioning)**.\n6. **Fluid Management:** íê°€ ë¶€ì–´ ìˆìœ¼ë¯€ë¡œ **Dry lung** (ì´ë‡¨ì œ ì‚¬ìš© ë“±)ì„ ìœ ì§€í•˜ëŠ” ê²ƒì´ ìœ ë¦¬í•©ë‹ˆë‹¤.\n---\n# ğŸ« USMLE Deep Dive: Lung Cancer & Solitary Pulmonary Nodule (SPN)\n**Topic:** Lung Cancer Screening, Nodule Algorithm, Cancer Types, Paraneoplastic Syndromes\n## ğŸŒ³ The Big Picture: Diagnosis Tree\níì•” ë¬¸ì œì˜ 80%ëŠ” \"X-rayì—ì„œ ë­ê°€ ë³´ì´ëŠ”ë° ë‹¤ìŒ ì¡°ì¹˜ëŠ”?\"ì…ë‹ˆë‹¤.\n`Lung Mass/Nodule on CXR\nâ”‚\nâ”œâ”€â”€ 1. Old X-ray Comparison (ê°€ì¥ ë¨¼ì €!)\nâ”‚   â”œâ”€â”€ Unchanged > 2 years: Benign (Stop workup)\nâ”‚   â””â”€â”€ New or Changed: Go to CT Chest\nâ”‚\nâ”œâ”€â”€ 2. CT Chest Characterization\nâ”‚   â”œâ”€â”€ Low Risk (Small < 0.8cm, Smooth, Calcified): Serial CT\nâ”‚   â”œâ”€â”€ Intermediate Risk: PET scan or Biopsy\nâ”‚   â””â”€â”€ High Risk (Large > 2cm, Spiculated, Smoker): Excision/Biopsy\nâ”‚\nâ””â”€â”€ 3. Diagnosis & Staging\n    â”œâ”€â”€ Central Lesion: Bronchoscopy (EBUS)\n    â””â”€â”€ Peripheral Lesion: CT-guided Biopsy (Transthoracic)`\n---\n## 1. Screening Guidelines (USPSTF 2021 Update)","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-105","focus_area":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"USMLEëŠ” ìµœì‹  ê°€ì´ë“œë¼ì¸ì„ ì‚¬ë‘í•©ë‹ˆë‹¤. ìˆ˜ì¹˜ê°€ ë°”ë€Œì—ˆìœ¼ë‹ˆ ê¼­ ì—…ë°ì´íŠ¸í•˜ì„¸ìš”.\n- **ëŒ€ìƒ:** **50ì„¸ ~ 80ì„¸** (ê³¼ê±° 55ì„¸ì—ì„œ ë‚®ì•„ì§).\n- **í¡ì—°ë ¥:** **20 Pack-year** ì´ìƒ (ê³¼ê±° 30ì—ì„œ ë‚®ì•„ì§).\n- **í˜„ì¬ ìƒíƒœ:** í˜„ì¬ í¡ì—°ìì´ê±°ë‚˜, ëŠì€ ì§€ **15ë…„ ì´ë‚´**.\n- **ê²€ì‚¬:** **Low-dose CT (LDCT)** ë§¤ë…„ ì‹œí–‰ (Every year).\n    - *X-rayëŠ” ìŠ¤í¬ë¦¬ë‹ ë„êµ¬ê°€ ì•„ë‹˜!*\n---\n## 2. Solitary Pulmonary Nodule (SPN) Algorithm\nìš°ì—°íˆ ë°œê²¬ëœ \"ë™ì „ ëª¨ì–‘ì˜ ìŒì˜(Coin lesion)\"ì„ ì–´ë–»ê²Œ í•  ê²ƒì¸ê°€?\n### A. First Step: Comparison\n- ë¬´ì¡°ê±´ **ê³¼ê±° ì˜ìƒ(Previous X-ray)**ì„ ì°¾ìœ¼ì„¸ìš”.\n- **2ë…„ê°„ í¬ê¸° ë³€í™”ê°€ ì—†ë‹¤** = **Benign** (ì–‘ì„±). ì¶”ê°€ ê²€ì‚¬ ë¶ˆí•„ìš”.\n### B. Risk Stratification (Benign vs Malignant)\n| **Feature** | **Benign (ì°©í•œ ë†ˆ)** | Intermediate | **Malignant (ë‚˜ìœ ë†ˆ)** |\n| --- | --- | --- | --- |\n| **Size** | < 0.8 cm |  | **> 2.0 cm** (í¬ë©´ ë‚˜ì˜ë‹¤) |\n| **Margin** | Smooth (ë§¤ëˆ) |  | **Spiculated** (ì¹¨ìƒ, ì‚ì£½ì‚ì£½) |\n| **Calcification** | **Popcorn** (Hamartoma), Concentric |  | Eccentric (í•œìª½ìœ¼ë¡œ ì¹˜ìš°ì¹¨), Sparse |\n| **Patient** | Non-smoker, Young (<45) |  | Smoker, Older (>60) |\n|  | serial CT scan | PET scan or biopsy | ìˆ˜ìˆ ! straight to OR â˜…  |\n- *Popcorn Calcification* = **Hamartoma** (Pulmonary Hamartoma). ê°€ì¥ í”í•œ ì–‘ì„± ì¢…ì–‘. ê·¸ëƒ¥ ë‘¡ë‹ˆë‹¤.\n- eccentric ì•ˆì¢‹ìŒ.\n---\n## 3. Types of Lung Cancer (The \"Big 4\")\nì‹œí—˜ì—ì„œëŠ” \"í¡ì—°í•˜ëŠ” ë‚¨ìê°€ X ì¦ìƒìœ¼ë¡œ ì™”ë‹¤. ë¬´ìŠ¨ ì•”ì¸ê°€?\"ë¥¼ ë¬»ìŠµë‹ˆë‹¤.\nìœ„ì¹˜ì™€ paraneoplasaticì„ ì—°ê²°í•˜ì„¸ìš”.\n### A. Small Cell Lung Cancer (SCLC) - \"The Bad One\"\n- **ìœ„ì¹˜:** **Central** (ê¸°ê´€ì§€ ê·¼ì²˜).\n- **íŠ¹ì§•:** í¡ì—°ê³¼ ê°•ë ¥í•œ ì—°ê´€. ì „ì´ê°€ ë§¤ìš° ë¹ ë¦„ (ìˆ˜ìˆ  ë¶ˆê°€ëŠ¥).\n- **Paraneoplastic Syndromes (Neuroendocrine):**\n    1. **ACTH:** **Cushing Syndrome** (Moon face, Buffalo hump, ê³ í˜ˆë‹¹).\n    2. **SIADH:** **Hyponatremia** (ì €ë‚˜íŠ¸ë¥¨í˜ˆì¦, ì˜ì‹ ì €í•˜, Seizure).\n    3. **Lambert-Eaton Syndrome:** ê·¼ë ¥ ì•½í™” (ìš´ë™í•˜ë©´ í˜¸ì „ë¨ ddx MG), ì… ë§ˆë¦„. (Ca2+ ì±„ë„ ê³µê²©).\n- **ì¹˜ë£Œ:** **Chemotherapy + Radiation**. (ìˆ˜ìˆ  X).\n### B. Non-Small Cell Lung Cancer (NSCLC)\n- ìˆ˜ìˆ (Resection)ì´ ê°€ëŠ¥í•˜ë‹¤ë©´ ìˆ˜ìˆ ì´ ì›ì¹™ì…ë‹ˆë‹¤.\n- ìˆ˜ìˆ ê°€ëŠ¥ì—¬ë¶€: FEV1, DLCO ê²€ì‚¬. (FEV >1.5L, DLCO>60%) â˜…\n    - ì•ˆë˜ë©´, wedge resectionâ€¦\n- ë‹´ë°° ëŠì„ê±°ë©´ 4-8ì£¼ ì „ì— ëŠìœ¼ì„¸ìš”.\n    - 1-2ì „ì— ëŠìœ¼ë©´ ì˜¤íˆë ¤ ì•ˆì¢‹ì„ ìˆ˜ë„ ìˆìŒ. ëŠê³  ì§í›„ëŠ” mucus ì–‘ì´ ëŠ˜ê¸° ë•Œë¬¸.\n1. **Squamous Cell Carcinoma (í¸í‰ìƒí”¼ì„¸í¬ì•”):**\n    - **ìœ„ì¹˜:** **Central**. (Remember \"**S**\" for **S**moking, **S**entral).\n    - **íŠ¹ì§•:** **Cavitation** (ì¤‘ì•™ ê´´ì‚¬ lung abscessê°™ì´ ìƒê²¼ëŠ”ë° ê°ì—¼ ì§•í›„ê°€ ì—†ìŒ). **Keratin Pearls** (ë³‘ë¦¬).\n    - **Paraneoplastic:** **PTHrP** ë¶„ë¹„ â†’ **Hypercalcemia** (ë¼ˆ ì „ì´ ì—†ëŠ”ë° ì¹¼ìŠ˜ ë†’ìŒ). â†’ stone bones groans throans â˜…\n2. **Adenocarcinoma (ì„ ì•”):**\n    - **ìœ„ì¹˜:** **Peripheral** (í ê°€ì¥ìë¦¬).\n    - **íŠ¹ì§•:** **Most Common** (ì „ì²´ 1ìœ„). **Non-smoker**, **Female**ì—ì„œ ê°€ì¥ í”í•¨.\n    - ê´€ë ¨: Hypertrophic Osteoarthropathy (Clubbing, ì†ëª©/ë°œëª© í†µì¦).\n    - COPDí™˜ìì—ì„œ new clubbing â†’ search for cancer! â˜…\n3. **Large Cell Carcinoma:**\n    - **ìœ„ì¹˜:** Peripheral.\n    - beta hcg formation.\n    - **íŠ¹ì§•:** ì§„ë‹¨ ë°°ì œ í›„ ë‚¨ëŠ” ê²ƒ. ì˜ˆí›„ ë‚˜ì¨. **Gynecomastia**(ì—¬ì„±í˜• ìœ ë°© - breast tenderness) ìœ ë°œ ê°€ëŠ¥.\n---\n## 4. Special Scenarios & Complications\n### A. Pancoast Tumor (Superior Sulcus Tumor)","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-125","focus_area":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"íì˜ ê¼­ëŒ€ê¸°(Apex)ì— ìƒê¸´ ì•”ì´ ì£¼ë³€ ì‹ ê²½ì„ ëˆ„ë¦…ë‹ˆë‹¤.\n- **Triad:**\n    1. **Shoulder Pain:** ìƒì™„ì‹ ê²½ì´(Brachial plexus) ì¹¨ë²”.\n    2. **Horner's Syndrome:** êµê°ì‹ ê²½ì ˆ ì¹¨ë²”. (**Ptosis**ëˆˆêº¼í’€ ì²˜ì§, **Miosis**ë™ê³µ ì¶•ì†Œ, **Anhidrosis**ë¬´ë°œí•œ).\n    3. **Hand Muscle Atrophy:** C8-T1 ì‹ ê²½ ì¹¨ë²”.\n### B. SVC Syndrome (ìƒëŒ€ì •ë§¥ ì¦í›„êµ°)\n- **ì¦ìƒ:** ì•„ì¹¨ì— ì–¼êµ´ì´ í‰í‰ ë¶“ê³ (Facial plethora), ëª©ê³¼ ê°€ìŠ´ì˜ ì •ë§¥ì´ ëŠ˜ì–´ë‚¨(Distended veins). íŒ”ì„ ë“¤ë©´ ì–´ì§€ëŸ¬ì›€(Pemberton's sign).\n- **ì›ì¸:** Small Cell Lung Cancerê°€ SVCë¥¼ ëˆŒëŸ¬ì„œ ë°œìƒ.\n- **ì²˜ì¹˜:** ì‘ê¸‰ ë°©ì‚¬ì„  ì¹˜ë£Œ(Radiation)ë¡œ ì¢…ì–‘ í¬ê¸° ì¤„ì´ê¸°.\n### C. Carcinoid Tumor\n- **íŠ¹ì§•:** ì‹ ê²½ë‚´ë¶„ë¹„ ì¢…ì–‘. ë§¹ì¥(Appendix) ë‹¤ìŒìœ¼ë¡œ íì— í˜¸ë°œ.\n- í ì‹¤ì§ˆì— ìƒê¸°ëŠ” ê²ƒì´ ì•„ë‹ˆë¼ ê¸°ë„ì— ìƒê¹€. â†’ ê°í˜ˆ ì¦ìƒ, obstruction ê°€ëŠ¥ â†’ obstruction ì§„í–‰ì‹œ mucus plugging, pneumoniae í˜¸ë°œ\n- 20ëŒ€, ì²­ì†Œë…„ì´ ì§€ì†ì ì¸ ê°™ì€ ê³³ì—ì„œ íë ´ë°œìƒì‹œ ì˜ì‹¬ê°€ëŠ¥.\n    - recurrent pneumoia in the same lobe â†’ cancer! â†’ CT scan (no X ray)\n- **ì¦ìƒ:** **Carcinoid Syndrome** (Flushing, Diarrhea, Wheezing).\n    - *ì£¼ì˜:* íì— ìƒê¸´ CarcinoidëŠ” ê°„(Liver)ì„ ì•ˆ ê±°ì¹˜ê³  ë°”ë¡œ ì „ì‹ ìœ¼ë¡œ ë¬¼ì§ˆì„ ì˜ê¸° ë•Œë¬¸ì—, ê°„ ì „ì´ê°€ ì—†ì–´ë„ ì¦ìƒì´ ë‚˜íƒ€ë‚  ìˆ˜ ìˆìŒ.\n---\n## ğŸ¯ Recap (High Yield Summary)\nì´ê²ƒë§Œì€ ê¼­ ì™¸ìš°ê³  ì‹œí—˜ì¥ì— ë“¤ì–´ê°€ì„¸ìš”.\n1. **Nodule First Step:** **Compare with Old X-ray**. 2ë…„ê°„ ë³€í™” ì—†ìœ¼ë©´ Benign.\n2. **Screening:** **Age 50-80**, **20 Pack-year**, Quit < 15y â†’ **Annual Low-dose CT**.\n3. **Small Cell (SCLC):** **Central**, **ACTH(Cushing)/SIADH(Low Na)**, **Chemo/Rad** (No Surgery).\n4. **Squamous Cell:** **Central**, **Hypercalcemia (PTHrP)**.\n5. **Adenocarcinoma:** **Peripheral**, **Non-smoker**.\n6. **Pancoast:** ì–´ê¹¨ í†µì¦ + **Horner's Syndrome** (ëˆˆ ì‘ì•„ì§).\n7. **Hoarseness:** ì‰° ëª©ì†Œë¦¬ê°€ ë‚˜ë©´ **Recurrent Laryngeal Nerve** ì¹¨ë²” â†’ ìˆ˜ìˆ  ë¶ˆê°€ëŠ¥(Unresectable) ì‹ í˜¸ì¼ ìˆ˜ ìˆìŒ.\n---\n# ğŸ« USMLE Deep Dive: Pulmonary Miscellaneous (Real)\n**Topic:** Chronic Cough, Hyperventilation (Tetany), HAPE vs Pneumonia, DAH, Pediatric (Choanal Atresia, CDH), Diaphragmatic Paralysis\n## 1. Chronic Cough (ë§Œì„± ê¸°ì¹¨)\nUSMLEê°€ ì‚¬ë‘í•˜ëŠ” \"ê¸°ì¹¨ì´ ì•ˆ ë©ˆì¶°ìš”\" ì‹œë‚˜ë¦¬ì˜¤ì…ë‹ˆë‹¤.\n- **ì •ì˜:** **8ì£¼ ì´ìƒ** ì§€ì†ë˜ëŠ” ê¸°ì¹¨. (ê°ê¸° ì•„ë‹˜).\n- **Step 1: Check Meds (ê°€ì¥ ë¨¼ì €!)**\n    - í™˜ìê°€ **ACE Inhibitor (Lisinopril ë“±)**ë¥¼ ë¨¹ê³  ìˆëŠ”ì§€ í™•ì¸í•˜ì„¸ìš”. ì•½ì„ ëŠê³  ARBë¡œ ë°”ê¾¸ëŠ” ê²Œ ì •ë‹µì…ë‹ˆë‹¤.\n- **The Big 3 Causes: ì´ê±° í•´ê²°í•´ë³´ê³  ì•ˆë˜ë©´ ê·¸ë•Œ x-ray ì°ëŠ”ë‹¤!**\n    1. **UACS (Upper Airway Cough Syndrome, í›„ë¹„ë£¨):**\n        - **Trap:** ë¶€ë¹„ë™ CTë¶€í„° ì°ì§€ ë§ˆì„¸ìš”.\n        - **Tx:** **1ì„¸ëŒ€ í•­íˆìŠ¤íƒ€ë¯¼ì œ (Chlorpheniramine, Brompheniramine)**. (ì¡¸ë¦° ì•½).\n        - *Why?* ì•Œë ˆë¥´ê¸° íš¨ê³¼ê°€ ì•„ë‹ˆë¼, **Anticholinergic(í•­ì½œë¦°)** íš¨ê³¼ë¡œ ì½§ë¬¼ì„ ë§ë ¤ë²„ë¦¬ëŠ” ê²Œ ì¹˜ë£Œì˜ í•µì‹¬ì´ê¸° ë•Œë¬¸ì…ë‹ˆë‹¤. ì‹ ì•½(Loratadine ë“±)ì€ ë„ˆë¬´ ê¹¨ë—í•´ì„œ íš¨ê³¼ê°€ ì—†ìŠµë‹ˆë‹¤.\n    2. **Asthma:** PFT í™•ì¸.\n    3. **GERD:** ì—­ë¥˜ ì¦ìƒ í™•ì¸.\n## 2. Hyperventilation Syndrome & Tetany\nì Šì€ í™˜ìê°€ ê³¼í˜¸í¡ìœ¼ë¡œ ì‘ê¸‰ì‹¤ì— ì™”ëŠ”ë° ì†ì´ ë’¤í‹€ë¦½ë‹ˆë‹¤.\n- **Presentation:** ë¶ˆì•ˆ(Anxiety) + ê³¼í˜¸í¡ + **Carpopedal Spasm** (ì†ë°œì´ ì˜¤ê·¸ë¼ë“¦, Tetany).\n- **Mechanism (Physiology): ê³¼í•œ ì•Œì¹¼ë¦¬ì¦ì—ì„œëŠ” hypocalcemiaì¦ìƒì´ ë‚˜íƒ€ë‚œë‹¤.**\n    - ê³¼í˜¸í¡ â†’ CO2 ë‚ ì•„ê° â†’ Respiratory Alkalosis (pH ìƒìŠ¹) â†’ ì•Œë¶€ë¯¼(Albumin ìŒì´ì˜¨)ì´ ìˆ˜ì†Œì´ì˜¨(H+)ì„ ë±‰ê³  ëŒ€ì‹  **ì¹¼ìŠ˜(Calcium)ê³¼ ê²°í•©** â†’ í˜ˆì¤‘ **Ionized Calcium(ì´ì˜¨í™” ì¹¼ìŠ˜)** ë†ë„ ê¸‰ë½ â†’ **Tetany** ë°œìƒ.\n    - *Note:* Total Calciumì€ ì •ìƒì…ë‹ˆë‹¤. **Ionized Calcium**ì´ ë‚®ì€ ê²Œ ë²”ì¸ì…ë‹ˆë‹¤.\n- **Management:**\n    - **Paper Bag (ì¢…ì´ë´‰íˆ¬):** **ê¸ˆê¸°(Contraindicated)!** ì €ì‚°ì†Œì¦(Hypoxia) ìœ„í—˜ì´ ìˆì–´ ë” ì´ìƒ ì“°ì§€ ì•ŠìŠµë‹ˆë‹¤.\n    - **Tx:** **Breathing Retraining** (í˜¸í¡ ì½”ì¹­) + ë¶ˆì•ˆ ì¡°ì ˆ(Benzodiazepines).\n## 3. High Altitude Pulmonary Edema (HAPE):\nì €ì‚°ì†Œì¦ â†’ì¼ë¶€ë¶„í˜ˆê´€ìˆ˜ì¶•, ì¼ë¶€ë¶„ íë¶€ì¢… â†’ íë ´ê°™ì•„ë³´ì„","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-145","focus_area":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","tags":["usmle-step2","core","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"ê³ ì‚°ë³‘ì´ íë ´ì²˜ëŸ¼ ë³´ì¼ ë•Œ ê°ë³„ë²•ì…ë‹ˆë‹¤. SOB, infiltrates, crackles..\n- ë†’ì€ ê³ ë„ì—ì„œ ì‚°ì†Œ ë¶€ì¡±\nâ†’ hypoxic vasoconstriction only ì¼ë¶€ë¶€ìœ„ë§Œ!\nâ†’ í˜ˆê´€ ìˆ˜ì¶• ì•ˆëœë°ëŠ” í˜ˆê´€ íˆ¬ê³¼ì„±ì´ ì˜¤íˆë ¤ ì¦ê°€, í˜ˆë¥˜ëŸ‰ ì¦ê°€\nâ†’ íë¶€ì¢… ë°œìƒ\n- **Scenario:** ê³ ì§€ëŒ€ ë“±ë°˜ í›„ ìˆ¨ì´ ì°¨ê³  X-rayì— ì¹¨ìœ¤(Infiltrates)ì´ ë³´ì„. íë ´(Pneumonia)ê³¼ ë˜‘ê°™ì´ ìƒê²¼ìŠµë‹ˆë‹¤.\n- **Differentiation (HAPE vs Pneumonia):**\n    1. **Timing:** HAPEëŠ” ë„ì°© í›„ **2~4ì¼ ë‚´** ê¸‰ê²©íˆ ë°œìƒ.\n    2. **Labs:** **Procalcitonin**. (íë ´ì€ ë†’ìŒ, HAPEëŠ” **ì •ìƒ**).\n    3. **Response:** HAPEëŠ” **ì‚°ì†Œ(O2)**ë§Œ ì¤˜ë„ ë“œë¼ë§ˆí‹±í•˜ê²Œ ì¢‹ì•„ì§. (íë ´ì€ í•­ìƒì œ ì—†ìœ¼ë©´ ëŠë¦¼).\n## 4. Diffuse Alveolar Hemorrhage (DAH) : ë£¨í‘¸ìŠ¤, ë² ê²Œë„ˆ\níí¬ì— í”¼ê°€ ì°¨ëŠ” ë³‘ì…ë‹ˆë‹¤. (Lupus, Wegener's ë“± ìê°€ë©´ì—­ì§ˆí™˜).\n- **Biggest Trap:** í™˜ìì˜ **50%ëŠ” ê°í˜ˆ(Hemoptysis)ì´ ì—†ìŠµë‹ˆë‹¤**. (í”¼ê°€ íí¬ì— ê°‡í˜€ì„œ ë°–ìœ¼ë¡œ ì•ˆ ë‚˜ì˜´). ê°í˜ˆ ì—†ë‹¤ê³  ë°°ì œí•˜ë©´ ì•ˆ ë©ë‹ˆë‹¤. â˜…\n- **Diagnosis:**\n    - **Bronchoscopy with Lavage:** ì„¸ì²™ì„ í• ìˆ˜ë¡ ì ì  **ë” ë¶‰ì€ ë¬¼(Bloodier aliquots)**ì´ ë‚˜ì˜´.\n- **Tx:** ê¸°ì €ì§ˆí™˜ì¹˜ë£Œ (i.e. ê³ ìš©ëŸ‰ ìŠ¤í…Œë¡œì´ë“œ). (í•­ì‘ê³ ì œ ê¸ˆê¸°).\n## 5. Decompression Sickness:\në…¹ì•„ìˆë˜ ì§ˆì†Œê°€ ë‹¤ë¥¸ê³³ (ê´€ì ˆ, ë‡Œ, í)ë¡œ ê°„ë‹¤.\n<aside>\nğŸ’¡\níƒ„ì‚°ìº” ë”¸ë•Œ ìƒìƒ\në…¹ì•„ìˆë˜ ì§ˆì†Œê°€ ê³µê¸°ë°©ìš¸ì´ ë˜ì–´ì„œ ë‚˜ì™€ì„œ ë‹¤ë¥¸ê³³(ê´€ì ˆ, ë‡Œ, í)ë¡œ ê°„ë‹¤.\n</aside>\n- Diverê°€ air tankì—ì„œ ë§ˆì‹  nitrogenì´ í•˜ê°•í•˜ë©´ì„œ ê³ ì••ë ¥ì— í”¼ì— ì˜ ë…¹ìŒ\n- ê¸‰ê²©í•œ ìƒìŠ¹ì— ì˜í•´ì„œ ì••ë ¥ì´ ë‚®ì•„ì§€ë©´ì„œ nitrogenì´ ë”ì´ìƒ ë…¹ì§€ ì•Šê³  ê³µê¸°ë°©ìš¸ë¡œ ë‚˜ì˜´\n- ê³µê¸°ë°©ìš¸ì´ ê´€ì ˆì— ê°€ë©´ type 1 (MSK), ê³µê¸° ë°©ìš¸ì´ systemic circulationìœ¼ë¡œ íí˜ˆê´€, ë‡Œí˜ˆê´€ìœ¼ë¡œ ê°€ë©´ type 2.\n- ì¹˜ë£Œ: IV hydration, hyperbaric oxygen\n---","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-165","focus_area":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"recap_summary","text":"**Recap (One-Liner)**\n- **Chronic Cough:** ACEi í™•ì¸ â†’ UACSë©´ **1ì„¸ëŒ€ í•­íˆìŠ¤íƒ€ë¯¼ì œ**.\n- **Tetany:** ê³¼í˜¸í¡ â†’ **Low Ionized Calcium**. ì¢…ì´ë´‰íˆ¬ ì“°ì§€ ë§ˆë¼.\n- **HAPE:** ì‚°ì†Œ ì£¼ë©´ ë°”ë¡œ ì¢‹ì•„ì§. Procalcitonin ì •ìƒ.\n- **DAH:** ê°í˜ˆ ì—†ì„ ìˆ˜ë„ ìˆìŒ. BALì—ì„œ í”¼ ë‚˜ì˜´.\n- **Blue Feeding/Pink Crying:** **Choanal Atresia**.\n- **Scaphoid Abdomen:** **CDH**. **Bag-Mask ê¸ˆì§€**.\n- **Sniff Test:** Paradoxical movement = **Diaphragmatic Paralysis**.\nì´ì œ íŒŒì¼ ë‚´ìš©ê³¼ ì •í™•íˆ ì¼ì¹˜í•  ê²ƒì…ë‹ˆë‹¤. í˜¼ë€ì„ ë“œë ¤ ì£„ì†¡í•©ë‹ˆë‹¤. ì´ ë‚´ìš©ìœ¼ë¡œ ì •ë¦¬í•´ ë‘ì‹œë©´ ë©ë‹ˆë‹¤.\n---\n---\n---\n# ğŸ« USMLE Step 2 Deep Dive: Pediatric Pulmonology (ì†Œì•„ í˜¸í¡ê¸°í•™)\nì´ ê°•ì˜ëŠ” USMLE Step 2ë¥¼ ìœ„í•´ ê°€ì¥ ì¤‘ìš”í•œ **ì†Œì•„ í˜¸í¡ê¸°í•™**ì„ ë‹¤ë£¹ë‹ˆë‹¤. ë‹¨ìˆœí•œ ìš©ì–´ ì •ì˜(Step 1 ìˆ˜ì¤€)ë¥¼ ë„˜ì–´, **ê´€ë¦¬(Management), ì„ìƒ ì¶”ë¡ (Clinical Reasoning), ê·¸ë¦¬ê³  ì‹œí—˜ í•¨ì • í”¼í•˜ê¸°**ì— ì§‘ì¤‘í•©ë‹ˆë‹¤.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-176","focus_area":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","tags":["usmle-step2","core","recap","treatment"]}
{"chunk_type":"transcript_chunk","text":"## 1. Introduction: Step 2ë¥¼ ìœ„í•œ ì‚¬ê³ ë°©ì‹ ì „í™˜ (Mindset Shift)\n- **Step 1 vs. Step 2:** ê¸°ì „(Mechanism)ì„ ë¬»ëŠ” ë‹¨ê³„ì—ì„œ **\"ë‹¤ìŒ ë‹¨ê³„ëŠ” ë¬´ì—‡ì¸ê°€?(What is the next best step?)\"**ë¥¼ ë¬»ëŠ” ë‹¨ê³„ë¡œ ì´ë™í•´ì•¼ í•©ë‹ˆë‹¤.\n- **ì„ìƒì  ì‹œë‚˜ë¦¬ì˜¤:** íŒŒë€ ì•„ê¸°(Blue baby), ì§ˆì‹í•˜ëŠ” ìœ ì•„(Choking toddler), ì½” ê³ ëŠ” ì–´ë¦°ì´(Snoring kid) ë“±ì˜ ì„ìƒ ìƒí™©(Vignette)ì´ ì£¼ì–´ì§‘ë‹ˆë‹¤.\n- **ê²°ì •:** ë³‘ë¦¬í•™ì  ì§€ì‹ë„ ì¤‘ìš”í•˜ì§€ë§Œ, **CTë¥¼ ì°ì„ ê²ƒì¸ê°€? ì‚½ê´€(Intubate)í•  ê²ƒì¸ê°€? ì•ˆì‹¬ì‹œí‚¬ ê²ƒì¸ê°€(Reassure)?** ë¥¼ ê²°ì •í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤.\n- **ë†’ì€ ì¤‘ìš”ë„:** ì†Œì•„ì˜ ê¸°ë„ëŠ” ë¹¨ëŒ€ë§Œí¼ ì‘ê³ , íëŠ” ì´ˆ ë‹¨ìœ„ë¡œ ê¸‰ê²©í•œ ìƒë¦¬í•™ì  ë³€í™”ë¥¼ ê²ªê¸° ë•Œë¬¸ì— ë§¤ìš° ì¤‘ìš”í•©ë‹ˆë‹¤.\n## 2. ì ‘ê·¼ í”„ë ˆì„ì›Œí¬ (Framework) ğŸ§ \nì—°ëŒ€ê¸°ì (Chronologically) ë° í•´ë¶€í•™ì (Anatomically) ì ‘ê·¼ë²•ì„ ì‚¬ìš©í•©ë‹ˆë‹¤.\n1. **ì‹ ìƒì•„ ê¸°ë„ (Newborn Airway):** êµ¬ì¡°ì  ë§‰í˜ (ì˜ˆ: Choanal Atresia).\n2. **í ì¡°ì§ (Lung Tissue):** NRDS (ì‹ ìƒì•„ í˜¸í¡ê³¤ë€ ì¦í›„êµ°), íê³ í˜ˆì••.\n3. **ìœ ì•„ê¸° (Toddler Years):** ì™¸ë¶€ í™˜ê²½ê³¼ì˜ ìƒí˜¸ì‘ìš© (ì˜ˆ: ì´ë¬¼ì§ˆ í¡ì¸).\n4. **ìˆ˜ë©´ ë° í–‰ë™ (Sleep & Behavioral):** ìˆ˜ë©´ ë¬´í˜¸í¡ì¦(OSA), í˜¸í¡ ì •ì§€ ë°œì‘(Breath-holding spells).\n5. **í™˜ê²½ì  ìœ„í—˜ (Environmental Risks):** SIDS (ì˜ì•„ ëŒì—°ì‚¬ ì¦í›„êµ°), ìµì‚¬(Drowning).\n---\n## 3. ì‹ ìƒì•„ ê¸°ë„ (Newborn Airway): Choanal Atresia (í›„ë¹„ê³µ íì‡„)\nê°€ì¥ ìƒë¶€ ê¸°ë„ì—ì„œ ì‹œì‘í•˜ëŠ” êµ¬ì¡°ì  ë¬¸ì œì…ë‹ˆë‹¤.\n![image.png](LM_%20pulmo%202/image.png)\n### ğŸš© ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤: The Pink Cries, Blue Feeds\n- **ìˆ˜ìˆ˜ê»˜ë¼ ê°™ì€ ì¦ìƒ:** ì•„ê¸°ê°€ ì¡°ìš©íˆ ìˆê±°ë‚˜ ìˆ˜ìœ í•  ë•ŒëŠ” ì²­ìƒ‰ì¦(Cyanotic)ì„ ë³´ì´ê³  ê´´ë¡œì›Œí•˜ì§€ë§Œ, **ìš¸ê¸° ì‹œì‘í•˜ë©´ ë¶„í™ìƒ‰(Pink)ìœ¼ë¡œ ëŒì•„ì˜¤ê³  ê±´ê°•í•´ ë³´ì…ë‹ˆë‹¤.**\n- **ìƒë¦¬í•™ì  ì´ìœ :** ì‹ ìƒì•„ëŠ” **â˜… ì˜ë¬´ì  ë¹„ê°• í˜¸í¡ì (Obligate Nasal Breathers)**ì…ë‹ˆë‹¤.\n    - í•´ë¶€í•™ì ìœ¼ë¡œ ë†’ì€ í›„ë‘ê°œ(Epiglottis)ê°€ ì—°êµ¬ê°œ(Soft palate)ì™€ ë§ë¬¼ë ¤ ìˆ˜ìœ  ì¤‘ì—ë„ ìˆ¨ì„ ì‰´ ìˆ˜ ìˆê²Œ ë˜ì–´ ìˆìŠµë‹ˆë‹¤.\n    - í›„ë¹„ê³µ(Choana)ì´ ë¼ˆë‚˜ ë§‰ìœ¼ë¡œ ë§‰í˜€ ìˆìœ¼ë©´ ì½”ë¡œ ìˆ¨ì„ ì‰´ ìˆ˜ ì—†ì–´ ì‚¬ì‹¤ìƒ ì§ˆì‹ ìƒíƒœê°€ ë©ë‹ˆë‹¤.\n    - ìš¸ ë•ŒëŠ” ì…ì„ ì—´ì–´ êµ¬ê°• í˜¸í¡ì„ í•˜ë¯€ë¡œ ì‚°ì†Œ ê³µê¸‰ì´ ê°€ëŠ¥í•´ì§‘ë‹ˆë‹¤.\n### ğŸ©º ì§„ë‹¨ ë° ê´€ë¦¬ (Step 2 Key Steps)\n1. **â˜… ì²« ë²ˆì§¸ ë‹¨ê³„ (Bedside):** **ì¹´í…Œí„° í†µê³¼ ì‹œë„ (Pass a Catheter).**\n    - ì‘ì€ í¡ì… ì¹´í…Œí„°(6~8 Fr)ë¥¼ ì½§êµ¬ë©ìœ¼ë¡œ ë„£ì–´ ë¹„ì¸ë‘ë¡œ í†µê³¼ì‹œì¼œ ë´…ë‹ˆë‹¤.\n    - **ì €í•­ì´ ëŠê»´ì ¸ í†µê³¼í•˜ì§€ ëª»í•˜ë©´(Cannot pass catheter sign)**, ì¶”ì • ì§„ë‹¨ì´ ë©ë‹ˆë‹¤.\n2. **í™•ì§„ (Confirmation):** **CT ìŠ¤ìº”** (ê³¨ì„±ì¸ì§€ ë§‰ì„±ì¸ì§€ í™•ì¸, ìˆ˜ìˆ  ê³„íš ìˆ˜ë¦½).\n3. **ì–‘ì¸¡ì„±(Bilateral) vs. í¸ì¸¡ì„±(Unilateral):**\n    - **ì–‘ì¸¡ì„±:** **ì‘ê¸‰ ìƒí™©(Emergency).** ì¦‰ì‹œ êµ¬ê°• ê¸°ë„(Oral airway) í™•ë³´ ë˜ëŠ” ì‚½ê´€ í•„ìš”.\n    - **í¸ì¸¡ì„±:** ì‹ ìƒì•„ê¸°ì— ë†“ì¹  ìˆ˜ ìˆìœ¼ë©°, í•™ë ¹ê¸°ì— **ë§Œì„±ì ì¸ í•œìª½ ì½§ë¬¼(Chronic one-sided nasal discharge)**ë¡œ ë‚˜íƒ€ë‚  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n### ğŸ§¬ CHARGE ì¦í›„êµ° ì—°ê´€ì„±\nChoanal Atresia í™˜ìì˜ ì•½ 50%ëŠ” CHARGE ì¦í›„êµ°ì„ ë™ë°˜í•©ë‹ˆë‹¤. ì‹œí—˜ì—ì„œëŠ” í•œ ê°€ì§€ ë‹¨ì„œë¥¼ ì£¼ê³  ë‚˜ë¨¸ì§€ë¥¼ ë¬»ìŠµë‹ˆë‹¤.\n- **C:** **Coloboma** (ëˆˆì˜ ê²°ì†, ì—´ì‡  êµ¬ë© ëª¨ì–‘ ë™ê³µ).\n- **H:** **Heart defects** (ì‹¬ì¥ ê¸°í˜• - TOF, VSD, ASD ë“±). **â˜… ëª¨ë“  í™˜ìì—ê²Œ ì‹¬ì¥ì´ˆìŒíŒŒ(Echocardiogram) í•„ìˆ˜.**\n- **A:** **Atresia of the choanae.**\n- **R:** **Retardation** of growth and development.\n- **G:** **Genital hypoplasia** (ì ë³µê³ í™˜, ì‘ì€ ìŒê²½ ë“±).\n- **E:** **Ear anomalies** (ê·€ ê¸°í˜•, ë‚œì²­). **â˜… ì²­ë ¥ ê²€ì‚¬(Audiometry) í•„ìˆ˜.**\n- **í™•ì§„:** CHD7 ìœ ì „ì ë³€ì´ ê²€ì‚¬.\n---\n## 4. í ì¡°ì§ (Lung Tissue): NRDS (ì‹ ìƒì•„ í˜¸í¡ê³¤ë€ ì¦í›„êµ°)\në¯¸ìˆ™ì•„(Preemie) í˜¸í¡ë¶€ì „ì˜ ê°€ì¥ í”í•œ ì›ì¸ì…ë‹ˆë‹¤.\n### ğŸ§ª ë³‘íƒœìƒë¦¬: Surfactant Deficiency (ê³„ë©´í™œì„±ì œ ê²°í•)","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-186","focus_area":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","tags":["usmle-step2","core","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"- **í•µì‹¬ ë¬¸ì œ:** ë¯¸ìˆ™ì•„ëŠ” **ê³„ë©´í™œì„±ì œ(Surfactant)**ê°€ ë¶€ì¡±í•©ë‹ˆë‹¤.\n- **LaPlaceì˜ ë²•ì¹™ (P = 2T/r):**\n    - ë¯¸ìˆ™ì•„ì˜ íí¬ëŠ” ë°˜ì§€ë¦„(r)ì´ ë§¤ìš° ì‘ìŠµë‹ˆë‹¤.\n    - ê³„ë©´í™œì„±ì œê°€ ì—†ìœ¼ë©´ í‘œë©´ì¥ë ¥(T)ì„ ì¤„ì´ì§€ ëª»í•´, íí¬ë¥¼ ì—´ì–´ë‘ê¸° ìœ„í•œ ì••ë ¥(P)ì´ ì—„ì²­ë‚˜ê²Œ ì»¤ì§‘ë‹ˆë‹¤.\n    - **ê²°ê³¼:** ìˆ¨ì„ ë‚´ì‰´ ë•Œë§ˆë‹¤ íí¬ê°€ ì™„ì „íˆ ì°Œê·¸ëŸ¬ì§ (**Atelectasis**, ë¬´ê¸°í). ë‹¤ìŒ ìˆ¨ì„ ì‰´ ë•Œë§ˆë‹¤ ë§‰ëŒ€í•œ ì—ë„ˆì§€ê°€ ì†Œëª¨ë©ë‹ˆë‹¤.\n- **ì„ìƒ ì§•í›„:** ë™ë™ê±°ë¦¼(Grunting - PEEPì„ ë§Œë“¤ì–´ ê¸°ë„ ìœ ì§€ ì‹œë„), ì½” ë²Œë ê±°ë¦¼(Nasal flaring), í‰ë¶€ í•¨ëª°(Retractions).\n- **X-ray ì†Œê²¬:** **â˜… ë‚®ì€ í ìš©ì  (Low lung volumes) + ê°„ìœ ë¦¬ ìŒì˜ (Ground-glass appearance) + ê³µê¸° ê¸°ê´€ì§€ ìŒì˜ (Air bronchograms).**\n    - **Air bronchogram ì„¤ëª…:** ê±´ê°•í•œ íëŠ” ê³µê¸°(ê²€ì€ìƒ‰)ë¡œ ì°¨ ìˆì§€ë§Œ, NRDSì—ì„œëŠ” íí¬ê°€ ì°Œê·¸ëŸ¬ì§€ê³  ì•¡ì²´ë¡œ ì°¨ì„œ í•˜ì–—ê²Œ ë³´ì…ë‹ˆë‹¤(Opaque). ë°˜ë©´, ì—°ê³¨ë¡œ ì§€ì§€ë˜ëŠ” ê¸°ê´€ì§€ëŠ” ê³µê¸°ê°€ ì°¨ ìˆì–´ ê²€ê²Œ ë³´ì´ë¯€ë¡œ, í•˜ì–€ ë°°ê²½ ì†ì—ì„œ ê²€ì€ ë‚˜ë­‡ê°€ì§€ì²˜ëŸ¼ ë‘ë“œëŸ¬ì ¸ ë³´ì…ë‹ˆë‹¤.\n### ğŸ’Š ê´€ë¦¬ (Management)\n1. **ì˜ˆë°© (Best Treatment):** **ì‚°ì „ ìŠ¤í…Œë¡œì´ë“œ (Betamethasone).**\n    - ë¶„ë§Œ 48ì‹œê°„ ì „ íˆ¬ì—¬ ì‹œ íƒœì•„ì˜ 2í˜• íí¬ì„¸í¬ë¥¼ ìê·¹í•˜ì—¬ ê³„ë©´í™œì„±ì œ ìƒì„±ì„ ì´‰ì§„í•©ë‹ˆë‹¤.\n2. **í˜¸í¡ ë³´ì¡° (Respiratory Support):**\n    - **1ë‹¨ê³„:** **CPAP (Continuous Positive Airway Pressure).** ì§€ì†ì ì¸ ì–‘ì••ì„ ì œê³µí•˜ì—¬ íí¬ê°€ ì°Œê·¸ëŸ¬ì§€ì§€ ì•Šê²Œ 'ë¶€ëª©(Splint)' ì—­í• ì„ í•©ë‹ˆë‹¤.\n    - **ì‹¤íŒ¨ ê¸°ì¤€:** ì‚°ì†Œ ìš”êµ¬ëŸ‰ ì¦ê°€ (ì˜ˆ: FiO2 40% -> 50%).\n    - **2ë‹¨ê³„:** **ì‚½ê´€(Intubation) ë° ì™¸ë¶€ ê³„ë©´í™œì„±ì œ(Exogenous Surfactant) íˆ¬ì—¬.** íŠœë¸Œë¥¼ í†µí•´ ì§ì ‘ íë¡œ ì´ì£¼ë©´ ì¦‰ê°ì ì¸ íš¨ê³¼ê°€ ë‚˜íƒ€ë‚©ë‹ˆë‹¤.\n3. **í•©ë³‘ì¦ ì˜ˆë°©:** **BPD (ê¸°ê´€ì§€íì´í˜•ì„±ì¦).**\n    - ê¸°ê³„ì  í™˜ê¸°(ì••ë ¥, ìš©ëŸ‰ ì†ìƒ)ë¡œ ì¸í•œ í ì†ìƒì„ ë§‰ê¸° ìœ„í•´ ê°€ëŠ¥í•œ í•œ ë¹¨ë¦¬ íŠœë¸Œë¥¼ ì œê±°í•´ì•¼ í•©ë‹ˆë‹¤. (LISA/MIST ê°™ì€ ë¹„ì¹¨ìŠµì  íˆ¬ì—¬ë²•ë„ ìˆìŒ).\n    - **BPD ì •ì˜:** ìƒí›„ 28ì¼ ì´í›„ì—ë„ ì‚°ì†Œ ë³´ì¶©ì´ í•„ìš”í•œ ë¯¸ìˆ™ì•„. X-rayì—ì„œ ê±°í’ˆ ëª¨ì–‘(Bubbly/Cystic)ê³¼ ê³¼íŒ½ì°½ ì†Œê²¬ì„ ë³´ì„.\n---\n## 5. ì§€ì†ì„± ì‹ ìƒì•„ íê³ í˜ˆì•• (PPHN)\nNRDSì™€ ë¹„ìŠ·í•´ ë³´ì¼ ìˆ˜ ìˆì§€ë§Œ ì›ì¸ì´ ë‹¤ë¦…ë‹ˆë‹¤.\n### ğŸ©¸ ë³‘íƒœìƒë¦¬: ë°°ê´€ ë¬¸ì œ (Plumbing Problem)\n- í ì¡°ì§ ìì²´ëŠ” ê´œì°®ì§€ë§Œ, íí˜ˆê´€ì´ ê½‰ ë‹«í˜€ ìˆì–´(Clamped shut) í˜ˆì•¡ ìˆœí™˜ ì „í™˜(íƒœì•„ ìˆœí™˜ -> ì¶œìƒ í›„ ìˆœí™˜)ì— ì‹¤íŒ¨í•œ ìƒíƒœì…ë‹ˆë‹¤.\n- í˜ˆì•¡ì´ íë¥¼ ìš°íšŒí•˜ì—¬ ìš°ì‹¬ì‹¤ì—ì„œ **ë™ë§¥ê´€(PDA)**ì´ë‚˜ ë‚œì›ê³µ(Foramen Ovale)ì„ í†µí•´ ì „ì‹  ìˆœí™˜ìœ¼ë¡œ ë°”ë¡œ ë¹ ì ¸ë‚˜ê°‘ë‹ˆë‹¤ (Right-to-Left Shunt).\n### ğŸ©º ì§„ë‹¨ (Diagnosis)\n- **â˜… íŠ¹ì§•ì  ì†Œê²¬:** **ë¯¸ë¶„ì  ì²­ìƒ‰ì¦ (Differential Cyanosis).**\n    - ì˜¤ë¥¸ì†(Pre-ductal blood)ì˜ ì‚°ì†Œí¬í™”ë„ëŠ” ë†’ì§€ë§Œ(95%), ë°œ(Post-ductal blood)ì˜ ì‚°ì†Œí¬í™”ë„ëŠ” ë‚®ìŠµë‹ˆë‹¤(85%). **10% ì´ìƒì˜ ì°¨ì´**ê°€ ë‚˜ë©´ ì§„ë‹¨ì ì…ë‹ˆë‹¤.\n- **X-ray:** **íê°€ ê¹¨ë—í•¨(Clear lungs)** ë˜ëŠ” íí˜ˆê´€ ìŒì˜ ê°ì†Œ (NRDSì˜ í•˜ì–€ íì™€ ëŒ€ì¡°ë¨).\n### ğŸ’Š ì¹˜ë£Œ (Treatment)\n1. **ì‚°ì†Œ (Oxygen):** ê·¸ ìì²´ë¡œ ê°•ë ¥í•œ íí˜ˆê´€ í™•ì¥ì œì…ë‹ˆë‹¤.\n2. **â˜… Magic Bullet:** **í¡ì… ì‚°í™”ì§ˆì†Œ (Inhaled Nitric Oxide, iNO).**\n    - ì„ íƒì  íí˜ˆê´€ í™•ì¥ì œ. ì „ì‹  í˜ˆì••ì„ ë–¨ì–´ëœ¨ë¦¬ì§€ ì•Šê³  íë™ë§¥ë§Œ í™•ì¥ì‹œí‚µë‹ˆë‹¤.\n    - iNO ì‹¤íŒ¨ ì‹œ **ECMO** ê³ ë ¤.\n---\n## 6. ìœ ì•„ê¸° (Toddler): ì´ë¬¼ì§ˆ í¡ì¸ (Foreign Body Aspiration)\nì›€ì§ì„ì´ í™œë°œí•´ì§€ê³  ì…ìœ¼ë¡œ ëª¨ë“  ê²ƒì„ ê°€ì ¸ê°€ëŠ” ì‹œê¸°ì…ë‹ˆë‹¤.\n### ğŸ¥œ ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤\n- **íŠ¹ì§•:** **ê°‘ì‘ìŠ¤ëŸ¬ìš´ ë°œë³‘ (Sudden Onset).**\n    - ë©€ì©¡í•˜ê²Œ ë†€ë˜ ì•„ì´ê°€ ê°‘ìê¸° ê¸°ì¹¨, ì¼ì¼ê±°ë¦¼(Choking), ì²œëª…ìŒ(Wheezing)ì„ ë³´ì…ë‹ˆë‹¤. ì—´ì´ë‚˜ ì½§ë¬¼ ë“± ê°ì—¼ ì¦ìƒì€ ì—†ìŠµë‹ˆë‹¤.\n- **ìœ„ì¹˜:** í•´ë¶€í•™ì ìœ¼ë¡œ ë” ë„“ê³  ìˆ˜ì§ì— ê°€ê¹Œìš´ **ì˜¤ë¥¸ìª½ ì£¼ê¸°ê´€ì§€(Right Mainstem Bronchus)**ì— ì˜ ê±¸ë¦½ë‹ˆë‹¤.\n### ğŸ©º ì‹ ì²´ ê²€ì‚¬ ë° ì§„ë‹¨\n- **ì²­ì§„:** **â˜… ë‹¨ìŒì„± ì²œëª…ìŒ (Monophonic Wheeze).**\n    - ì²œì‹(Asthma)ì˜ ë‹¤ìŒì„± ì²œëª…ìŒ(Polyphonic wheeze - ì˜¤ì¼€ìŠ¤íŠ¸ë¼ì²˜ëŸ¼ ë‹¤ì–‘í•œ ìŒ)ê³¼ ë‹¬ë¦¬, ê³ ì •ëœ í•˜ë‚˜ì˜ íì‡„ ì§€ì ì—ì„œ ë‚˜ëŠ” ë‹¨ì¼ ìŒ(í”¼ë¦¬ ì†Œë¦¬)ì…ë‹ˆë‹¤.\n    - í™˜ì¸¡ì˜ í˜¸í¡ìŒ ê°ì†Œ(Diminished breath sounds).\n- **X-rayì˜ í•¨ì •:** **â˜… ì •ìƒ X-rayê°€ í¡ì¸ì„ ë°°ì œí•˜ì§€ ëª»í•¨.** (ë•…ì½© ë“±ì€ ë°©ì‚¬ì„  íˆ¬ê³¼ì„±ì´ë¼ ì•ˆ ë³´ì„).\n- **2ì°¨ì  ì§•í›„ (Ball-valve effect):**\n    - ìˆ¨ì„ ë“¤ì´ì‰´ ë•ŒëŠ” ê³µê¸°ê°€ ë“¤ì–´ê°€ì§€ë§Œ, ë‚´ì‰´ ë•ŒëŠ” ë§‰í˜€ì„œ ëª» ë‚˜ì˜´ -> **ê³µê¸° í¬íš (Air Trapping).**\n    - X-rayì—ì„œ í™˜ì¸¡ íì˜ **ê³¼íŒ½ì°½(Hyperinflation)**, íš¡ê²©ë§‰ì´ ëˆŒë¦¬ê³  ì‹¬ì¥ì´ ë°˜ëŒ€ìª½ìœ¼ë¡œ ë°€ë¦¬ëŠ” ì†Œê²¬ (ê±°ëŒ€í•œ Red Flag). ë°˜ëŒ€ë¡œ ì™„ì „íˆ ë§‰íˆë©´ ë¬´ê¸°íê°€ ì˜¬ ìˆ˜ë„ ìˆìŒ.\n### ğŸ’Š ê´€ë¦¬ (Management)","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-206","focus_area":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"- **ì˜ì‹¬ì´ ê°•ë ¥í•˜ë©´ (High Suspicion) (History, focal wheeze):** **X-rayê°€ ì •ìƒì´ë¼ë„** ìˆ˜ìˆ ì‹¤ë¡œ ì§í–‰í•´ì•¼ í•©ë‹ˆë‹¤.\n- **Gold Standard:** **â˜… ê²½ì§ì„± ê¸°ê´€ì§€ë‚´ì‹œê²½ (Rigid Bronchoscopy).**\n    - ì§„ë‹¨ê³¼ ì¹˜ë£Œë¥¼ ë™ì‹œì— í•©ë‹ˆë‹¤.\n    - **ì™œ Flexibleì´ ì•„ë‹Œ Rigidì¸ê°€?** ìœ ì—°í•œ ë‚´ì‹œê²½ì€ ì‹œì•¼ í™•ë³´ì—” ì¢‹ì§€ë§Œ ë¬¼ê±´ì„ ì§‘ê¸° ì–´ë µìŠµë‹ˆë‹¤. ê²½ì§ì„± ë‚´ì‹œê²½ì€ í™˜ê¸°ë„ ê°€ëŠ¥í•˜ê³ , í° ê²¸ì(Forceps)ë¥¼ ë„£ì–´ ë¯¸ë„ëŸ¬ìš´ ì´ë¬¼ì§ˆì„ ë‹¨ë‹¨íˆ ì¡ì„ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n### ğŸ‘ƒ ì½§ì† ì´ë¬¼ì§ˆ (Nasal Foreign Body)\n- **ì‹œë‚˜ë¦¬ì˜¤:** **ì¼ì¸¡ì„±(Unilateral)**, ì•…ì·¨ê°€ ë‚˜ëŠ”(Foul-smelling), ë†ì„± ì½§ë¬¼(Purulent discharge).\n- **ì£¼ì˜:** 3ì„¸ ì•„ì´ì˜ ë¶€ë¹„ë™ì—¼ì€ ê±°ì˜ ì–‘ì¸¡ì„±ì…ë‹ˆë‹¤. í•œìª½ì—ì„œë§Œ ëƒ„ìƒˆë‚˜ëŠ” ì½§ë¬¼ì´ ë‚˜ì˜¤ë©´ 100% ì´ë¬¼ì§ˆì…ë‹ˆë‹¤.\n- **ì‘ê¸‰ ìƒí™©:** **ë‹¨ì¶”í˜• ë°°í„°ë¦¬(Button Battery).**\n    - ì ë§‰ì˜ ìˆ˜ë¶„ê³¼ ë°˜ì‘í•´ ì „ë¥˜ë¥¼ ë°œìƒì‹œì¼œ ìˆ˜ì‚°í™”ë¬¼(Lye)ì„ ìƒì„±, **í™”í•™ì  í™”ìƒ ë° ì•¡í™” ê´´ì‚¬(Liquefactive necrosis)**ë¥¼ ìœ ë°œí•©ë‹ˆë‹¤. 2ì‹œê°„ ë§Œì— ë¹„ì¤‘ê²©ì´ë‚˜ ì‹ë„ ì²œê³µ ê°€ëŠ¥. **ì¦‰ì‹œ ì œê±° í•„ìš”.**\n- **ì œê±° íŒ:** **Parent's Kiss Technique.**\n    - ë¶€ëª¨ê°€ ì•„ì´ì˜ ì…ì— ì…ì„ ëŒ€ê³ , ì •ìƒ ì½§êµ¬ë©ì„ ë§‰ì€ ë’¤ ê°•í•˜ê²Œ ìˆ¨ì„ ë¶ˆì–´ë„£ì–´ ì´ë¬¼ì§ˆì„ íŠ€ì–´ë‚˜ì˜¤ê²Œ í•©ë‹ˆë‹¤.\n---\n## 7. ìˆ˜ë©´ ë° í–‰ë™ (Sleep & Behavioral)\n### ğŸ˜´ íì‡„ì„± ìˆ˜ë©´ ë¬´í˜¸í¡ì¦ (OSA) in Kids\n- **ì›ì¸:** ì„±ì¸(ë¹„ë§Œ)ê³¼ ë‹¬ë¦¬ ì†Œì•„ì˜ ì£¼ì›ì¸ì€ **í¸ë„ ë° ì•„ë°ë…¸ì´ë“œ ë¹„ëŒ€ (Adenotonsillar Hypertrophy).**\n- **ì¦ìƒ:** ì½”ê³¨ì´ë³´ë‹¤ **í–‰ë™ ë¬¸ì œ**ë¡œ ë‚˜íƒ€ë‚˜ëŠ” ê²½ìš°ê°€ ë§ìŠµë‹ˆë‹¤.\n    - **â˜… ì—­ì„¤ì  ê³¼ì‰í–‰ë™ (Paradoxical Hyperactivity):** ì¡¸ë ¤í•˜ì§€ ì•Šê³  ADHDì²˜ëŸ¼ ì‚°ë§Œí•˜ê³  ì¶©ë™ì ì…ë‹ˆë‹¤. (ADHD ì•½ ì²˜ë°© ì „ ìˆ˜ë©´ í™•ì¸ í•„ìˆ˜!)\n    - **ì´ì°¨ì„± ì•¼ë‡¨ì¦ (Secondary Enuresis):** ì†Œë³€ì„ ì˜ ê°€ë¦¬ë˜ ì•„ì´ê°€ ë°¤ì— ë‹¤ì‹œ ì‹¤ìˆ˜ë¥¼ í•¨. (ì‹¬ì¥ì´ í˜¸í¡ ë…¸ë ¥ìœ¼ë¡œ ì¸í•œ ìŒì••ì„ ì²´ì•¡ ê³¼ë‹¤ë¡œ ì˜¤ì¸í•˜ì—¬ ANP/BNP ë¶„ë¹„ -> ì´ë‡¨ ì‘ìš©).\n- **ì§„ë‹¨:** **ìˆ˜ë©´ë‹¤ì›ê²€ì‚¬ (Polysomnogram).** ì†Œì•„ ê¸°ì¤€ì€ ë” ì—„ê²©í•¨ (AHI 1~2 ì´ìƒì´ë©´ ë¹„ì •ìƒ).\n- **ì¹˜ë£Œ:** **í¸ë„ ë° ì•„ë°ë…¸ì´ë“œ ì ˆì œìˆ  (T&A).** ëŒ€ë¶€ë¶„ ì™„ì¹˜ë¨.\n### ğŸ˜¤ í˜¸í¡ ì •ì§€ ë°œì‘ (Breath-holding Spells)\n- **ìœ í˜• 1: ì²­ìƒ‰ì¦í˜• (Cyanotic Type)**\n    - **ìœ ë°œ ìš”ì¸:** ë¶„ë…¸(Anger), ì¢Œì ˆ(Frustration).\n    - **ê²½ê³¼:** ìš¸ë‹¤ê°€ -> ìˆ¨ì„ ë©ˆì¶”ê³  -> íŒŒë˜ì§€ê³  -> ê¸°ì ˆí–ˆë‹¤ê°€ -> **ì¦‰ì‹œ íšŒë³µë¨.**\n- **ìœ í˜• 2: ì°½ë°±í˜• (Pallid Type)**\n    - **ìœ ë°œ ìš”ì¸:** í†µì¦(Pain), ê³µí¬(Fear) (ì˜ˆ: ë¨¸ë¦¬ë¥¼ ë¶€ë”ªí˜).\n    - **ê¸°ì „:** **ë¯¸ì£¼ì‹ ê²½ ë°˜ì‚¬ (Vasovagal response).** ì‹¬ë°•ìˆ˜ ì €í•˜ -> ì°½ë°±í•´ì§ -> ê¸°ì ˆ.\n- **ê°ë³„ ì§„ë‹¨:** **ê°„ì§ˆ(Epilepsy)ê³¼ì˜ ì°¨ì´ì .**\n    - í˜¸í¡ ì •ì§€ ë°œì‘ì€ **ë°˜ë“œì‹œ ìœ ë°œ ìš”ì¸(Provocation)ì´ ìˆìŒ.**\n    - íšŒë³µì´ ë¹ ë¥´ê³  **ë°œì‘ í›„ í˜¼ëˆ(Post-ictal state)ì´ ì—†ìŒ.** (ê°„ì§ˆì€ íšŒë³µì— ì‹œê°„ ê±¸ë¦¼).\n- **ê´€ë¦¬:** **ì•ˆì‹¬ì‹œí‚¤ê¸° (Reassurance).** ë¶€ëª¨ì—ê²Œ ë¬´í•´í•˜ë‹¤ëŠ” ê²ƒì„ ì„¤ëª…í•©ë‹ˆë‹¤.\n- **â˜… Lab Test:** **ì²  ê²°í•ì„± ë¹ˆí˜ˆ (Iron deficiency anemia)** í™•ì¸. ì² ë¶„ ë¶€ì¡±ê³¼ ì—°ê´€ì„±ì´ ë†’ìœ¼ë©° ì¹˜ë£Œ ì‹œ ë¹ˆë„ê°€ ì¤„ì–´ë“¤ ìˆ˜ ìˆìŒ.\n---\n## 8. í™˜ê²½ì  ìœ„í—˜ (Environmental Risks)\n### ğŸ›Œ ì˜ì•„ ëŒì—°ì‚¬ ì¦í›„êµ° (SIDS)\n- **ì •ì˜:** 1ê°œì›”~1ì„¸ ì‚¬ì´ ì˜ì•„ì˜ ì„¤ëª…í•  ìˆ˜ ì—†ëŠ” ì‚¬ë§.\n- **Triple Risk Model:** ì·¨ì•½í•œ ì˜ì•„(ë‡Œê°„ ì´ìƒ) + ê²°ì •ì  ë°œë‹¬ ì‹œê¸°(2~4ê°œì›”) + ì™¸ë¶€ ìŠ¤íŠ¸ë ˆìŠ¤(ì—ë“œë ¤ ì¬ìš°ê¸° ë“±).\n- **ìœ„í—˜ ìš”ì¸:**\n    - **â˜… ì—ë“œë ¤ ì¬ìš°ê¸° (Prone sleeping) - ê°€ì¥ í° êµì • ê°€ëŠ¥í•œ ìœ„í—˜ ì¸ì.**\n    - í‘¹ì‹ í•œ ì¹¨êµ¬, ì—„ë§ˆì˜ í¡ì—°(ì‚°ì „/ì‚°í›„), ê³¼ì—´(Overheating), **ë¶€ëª¨ì™€ì˜ ì¹¨ëŒ€ ê³µìœ (Bed sharing - íŠ¹íˆ ì†ŒíŒŒë‚˜ ì•ˆë½ì˜ì).**\n- **ë³´í˜¸ ìš”ì¸:** **ë°© ê³µìœ (Room sharing - ì¹¨ëŒ€ëŠ” ë”°ë¡œ),** ê³µê°ˆì –ê¼­ì§€(Pacifier) ì‚¬ìš©.\n### ğŸŠ ìµì‚¬ (Drowning)\n- **ë³‘íƒœìƒë¦¬:** ë¬¼(ë‹´ìˆ˜/í•´ìˆ˜ ìƒê´€ì—†ìŒ)ì´ ê³„ë©´í™œì„±ì œë¥¼ ì”»ì–´ëƒ„ -> ë¬´ê¸°í(Atelectasis) -> V/Q ë¶ˆì¼ì¹˜ -> ì €ì‚°ì†Œì¦(Hypoxia) -> ARDS.\n- **ê´€ë¦¬:**\n    - **ì¦ìƒì´ ìˆë‹¤ë©´ (ê¸°ì¹¨, í˜¸í¡ìˆ˜ ì¦ê°€ ë“±):** **ìµœì†Œ 6~8ì‹œê°„ ë³‘ì› ê´€ì°°** í•„ìˆ˜. **ì§€ì—°ì„± íë¶€ì¢…(Delayed pulmonary edema)** ìœ„í—˜ ë•Œë¬¸.\n- **ì˜ì‹ ì—†ì´ êµ¬ì¡° ë˜ì—ˆì„ ê²½ìš°ì˜ˆí›„ ì¸ì:** **ì ìˆ˜ ì‹œê°„(Subversion duration) 5ë¶„ ë¯¸ë§Œ**ì´ ê°€ì¥ ì¤‘ìš”. ê·¸ ì™¸ ì¦‰ê°ì ì¸ ì‹¬íì†Œìƒìˆ (CPR) ì—¬ë¶€, ì´ˆê¸° ì‚°ë„(pH < 7.1ì€ ë‚˜ì¨).\n    - **ì˜ˆì™¸:** **ì–¼ìŒë¬¼(Icy cold water)**ì— ë¹ ì§„ ê²½ìš° ì‹ ê²½ ë³´í˜¸ íš¨ê³¼(Neuroprotective)ë¡œ ì¸í•´ ì¥ì‹œê°„ ì ìˆ˜ í›„ì—ë„ ìƒì¡´ ê°€ëŠ¥ì„±ì´ ìˆìŒ (ë“œë¬¼ì§€ë§Œ).\n---","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-226","focus_area":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","tags":["usmle-step2","core","pathophysiology"]}
{"chunk_type":"recap_summary","text":"## 7. âš¡ Rapid Fire Recap (í•µì‹¬ ìš”ì•½)\n| ìƒí™© (Scenario) | ì§„ë‹¨ (Diagnosis) | í•µì‹¬ ì¡°ì¹˜ (Key Action) |\n| --- | --- | --- |\n| **ì‹ ìƒì•„, í‰ì†Œ íŒŒë—ê³  ìš¸ë©´ ë¶„í™ìƒ‰** | **Choanal Atresia** | ì¹´í…Œí„° í†µê³¼ ì‹œë„ -> CT -> **ìˆ˜ìˆ ** (ì–‘ì¸¡ì„±ì€ ì‘ê¸‰) |\n| **ë¯¸ìˆ™ì•„, ë™ë™ê±°ë¦¼, ê°„ìœ ë¦¬ ìŒì˜ X-ray** | **NRDS** | CPAP -> (í•„ìš”ì‹œ) ì‚½ê´€ & Surfactant |\n| **ì²­ìƒ‰ì¦ ì•„ê¸°, í ê¹¨ë—í•¨, ì°¨ë³„ì  ì²­ìƒ‰ì¦** | **PPHN** | **Inhaled Nitric Oxide (iNO)** |\n| **ìœ ì•„, ê°‘ì‘ìŠ¤ëŸ¬ìš´ ê¸°ì¹¨, ë‹¨ìŒì„± ì²œëª…ìŒ** | **Foreign Body Aspiration** | **Rigid Bronchoscopy** (X-ray ì •ìƒì´ì–´ë„!) |\n| **í•œìª½ ì½§ë¬¼, ì•…ì·¨** | **Nasal Foreign Body** | ì œê±° (ë°°í„°ë¦¬ëŠ” ì‘ê¸‰!) |\n| **ì½” ê³ ëŠ” ì•„ì´, ë‚®ì— ì‚°ë§Œí•¨(ADHD?), ì•¼ë‡¨ì¦** | **Pediatric OSA** | **Adenotonsillectomy (T&A)** |\n| **ìš¸ë‹¤ê°€ íŒŒë˜ì§€ê³  ê¸°ì ˆ, ê¸ˆë°© íšŒë³µ** | **Breath-holding Spell** | ì•ˆì‹¬ì‹œí‚¤ê¸°, **ì² ë¶„(Ferritin) ì²´í¬** |\n| **ë¬¼ì— ë¹ ì§, ê¸°ì¹¨ ì¡°ê¸ˆ í•¨** | **Drowning (Risk of ARDS)** | **6~8ì‹œê°„ ë³‘ì› ê´€ì°°** (ì§‘ì— ë³´ë‚´ì§€ ë§ ê²ƒ!) |\n---\n## 8. ë§ˆì§€ë§‰ ì¡°ì–¸ (Final Thoughts)\nStep 2ëŠ” ì—¬ëŸ¬ë¶„ì˜ ê²°ë‹¨ë ¥ì„ í‰ê°€í•©ë‹ˆë‹¤. ë³‘ì„ ì•„ëŠ” ê²ƒë§Œìœ¼ë¡œëŠ” ë¶€ì¡±í•©ë‹ˆë‹¤. **ë¬´ì—‡ì„ í•  ê²ƒì¸ê°€(What to do)**ë¥¼ ì•Œì•„ì•¼ í•©ë‹ˆë‹¤.\n- CT ì „ì— ì¹´í…Œí„° ë¨¼ì €.\n- ì´ë¬¼ì§ˆ ì˜ì‹¬ë˜ë©´ CT ëŒ€ì‹  ë‚´ì‹œê²½.\n- NRDSì—ëŠ” ì‚½ê´€ ì „ì— CPAP.\n- ì•Œê³ ë¦¬ì¦˜ì„ ìˆ™ì§€í•˜ê³ , í™˜ìë¥¼ ì‹œê°í™”í•˜ì—¬, **ë‹¤ìŒ ë‹¨ê³„(Next Step)**ë¥¼ ì •í™•íˆ ì„ íƒí•˜ì„¸ìš”! Good luck! ğŸ€\nCo-host: \"A submarine, huh? I can see that.\"\nHost: \"Seriously. We are talking about pressure gradients, fluid dynamics, vacuum seals and, you know, catastrophic structural failures. But we aren't talking about engineering. We are talking about the human chest. Specifically, we are cracking open the high yield, high stakes world of pulmonary surgery for USMLE Step 2.\"\n# ğŸ« USMLE Step 2 Deep Dive: Pulmonary Surgery (í ìˆ˜ìˆ ) ì™„ì „ ì •ë³µ","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-242","focus_area":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","tags":["usmle-step2","core","recap","diagnosis","treatment","pathophysiology"]}
